Patent Assignment
Reel/Frame 007291/0979
Assignment of Assignor's Interest
Recorded: 1994-07-25
Pages: 3
Assignors
SKLAR, ROBERT
Executed: 1994-06-20
MARCHIONNI, MARK
Executed: 1994-06-20
GWYNNE, DAVID I.
Executed: 1994-06-20
Assignee
CAMBRIDGE NEUROSCIENCE
ONE KENDALL SQUARE, CAMBRIDGE, MASSACHUSETTS, 02129
Covered Property
(1)
Methods of Increasing Myotube Formation or Survival, or Muscle Cell Mitogenesis, Differentiation or Survival Using Neuregulin Ggf Iii
Patent:
7,115,554 →
Application:
08/209,204 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
May 21, 2001
From: CAMBRIDGE NEUROSCIENCE, INC.
To: CENES PHARMACEUTICALS, INC.
Reel/Frame 011812/0784 →
Assignment of Assignor's Interest
Sep 27, 2004
From: CENES PHARMACEUTICALS, INC.
To: ACORDA THERAPEUTIC, INC.
Reel/Frame 015823/0604 →
Security Interest
May 31, 2005
From: CENES PHARMACEUTICALS, INC.
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 016075/0555 →
Security Interest
Jun 10, 2016
From: ACORDA THERAPEUTICS, INC.; CIVITAS THERAPEUTICS, INC.; NEURONEX, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 038950/0436 →
Release of Security Interest
May 31, 2017
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NEURONEX, INC.; CIVITAS THERAPEUTICS, INC.; ACORDA THERAPEUTICS, INC.
Reel/Frame 042643/0878 →